Showing 1,941 - 1,960 results of 229,265 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 10 ((ng decrease) OR (a decrease)) ))', query time: 1.90s Refine Results
  1. 1941

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  2. 1942
  3. 1943
  4. 1944
  5. 1945
  6. 1946

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…C, Quantification of melanoma and melanocyte mitochondrial morphology after treatment with CNP or CCCP for 24 h according to Duvezin-Caubet et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0227926#pone.0227926.ref047" target="_blank">47</a>]: tubular (>5 μm), intermediate (0.55 μm), fragmented (< 0.5 μm). …”
  7. 1947
  8. 1948
  9. 1949
  10. 1950
  11. 1951
  12. 1952
  13. 1953

    IGFBP-3 decreases vascular tone by activating scavenger receptor-B1. by Yagna P. R. Jarajapu (316562)

    Published 2013
    “…A significant decrease in myogenic tone was observed at 100 (*P<0.02, n = 5) and 300 ng/ml (**P<0.01, n = 5) IGFBP-3. …”
  14. 1954

    Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011) by Dong-Won Lee (2208223)

    Published 2016
    “…<div><p>Background</p><p>A decrease in bone mineral density (BMD) is a systemic consequence of chronic obstructive pulmonary disease (COPD). …”
  15. 1955
  16. 1956
  17. 1957
  18. 1958
  19. 1959

    Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism by Qing-Yun Guo (2007082)

    Published 2019
    “…However, the mechanisms by which GABAergic system dysfunctions induce the pathophysiology of ASD remain unclear. We previously demonstrated that a selective type I 5α-reductase inhibitor SKF105111 (SKF) induced ASD-like behaviors, such as impaired sociability-related performance and repetitive grooming behaviors, in male mice. …”
  20. 1960